ECJ Judgment – Medicinal products for human use – Marketing authorisation for the generic medicinal product Zoledronic acid Hospira – zoledronic acid – Regulatory data protection period for the reference medicinal products Zometa and Aclasta, containing the active substance zoledronic acid – Directive 2001/83/EC – Regulation (EEC) No 2309/93 and Regulation (EC) No 726/2004 – Global marketing authorisation – Regulatory data protection period
T-67/13, [2015] EUECJ T-67/13
Bailii
European
European
Updated: 04 January 2022; Ref: scu.552373
